- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
- 10-Q Quarterly report
- 10.55 Excipient Manufacturing and Supply Agreement - King Pharmaceuticals, Inc.
- 10.56 Second Amendment to Lease - De Anza Enterprises
- 31.1 Certification of James E. Brown Pursuant to Rule 13A-14(A) Section 302
- 31.2 Certification of Matthew J. Hogan Pursuant to Rule 13A-14(A) Section 302
- 32.1 Certificate of James E. Brown Pursuant to 18 U.s.c. Section 1350
- 32.2 Certificate of Matthew J. Hogan Pursuant to 18 U.s.c. Section 1350
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of DURECT Corporation (the “Company”) on Form 10-Q for the period ending September 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James E. Brown, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
November 2, 2009
/s/ JAMES E. BROWN |
| James E. Brown |
| Chief Executive Officer |